drugset / Trial / NCT06513806

Granisetron Versus Pethidine in Treatment of Post Spinal Shivering in Cesarean Sections

NCT06513806

Phase 4 Completed 330 enrolled Ain Shams University
RandomizedParallel-groupDouble-blindTreatment

Summary

Granisetron Versus Pethidine in Treatment of Post Spinal Shivering in Cesarean Sections

Timeline

Start
2024-08-01
Primary completion
2024-09-25
Completion
2024-09-28

Drugs

EvaluationDrugModalityDoseRoute
Comparator Granisetron Other / unclassified 3 mg Intravenous
Comparator Pethidin Unknown 25 mg Intravenous

Indications

No indication recorded.